Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus
Table 1
Baseline characteristics of patients with end-stage renal disease and shunt occlusion.
Characteristic
End-stage renal disease patients with shunt occlusion (N =29)
Personal factors
Age
66.2 ± 11.2
Gender (Male)
13 (44.8)
BMI
23.4 ± 4.5
Smoking
2 (6.8)
Medical history
Hypertension
20 (68.9)
Hyperlipidemia
7 (24.1)
Coronary artery disease
3 (10.3)
Stroke
5 (17.2)
Diabetes mellitus
19 (65.5)
>8
10 (34.4)
Insulin use
10 (34.4)
Statin use
5 (17.2)
Antiplatelet use
8 (27.5)
Shunt condition
Prosthetic graft
16 (55.1)
Total occlusion
15 (51.7)
Urokinase use§
5 (17.2)
Repeated intervention§§
23 (79.3)
Gender: male, BMI: kg/m2, : %, data: n (%) or mean ± standard deviation. §: urokinase use during catheter intervention, §§: within a year after enrollment.
